EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

OGT enhances customer experience with new Cytocell website

New website makes it easier to access expert FISH advice  Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched a new version of its Cytocell® f...
Continue Reading →
Europe

BIA Separations and Nuvonis Technologies partner to support vaccine and gene therapy production

Agreement combines strengths in upstream and downstream process development BIA Separations, a leading biochromatography development and manufacturing company, and Nu...
Continue Reading →
Europe

Ascom announces visionary platform for data-driven era of healthcare

The Ascom Healthcare Platform bridges information gaps to optimize digital workflows and meet the demands of clinical care Ascom (SWX:ASCN.SW), a global solutions pro...
Continue Reading →
Europe

Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director

Creates new Scientific Committee and nominates Thomas Südhof as Chair Appoints Fabienne Lecorvaisier as Chair of the Audit Committee At its meeting held on Mar...
Continue Reading →
Europe

Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine

Presence of antibodies in nasal mucosa suggest vaccine-induced immune protection at source of infection IgA antibodies against RSV observed in both serum and m...
Continue Reading →
Europe

Medicalchain announces partnership with The Groves Medical Group

The pilot partnership will be open to over 30,000 patients  Medicalchain, the decentralised blockchain platform that enables secure, fast and transparent exchange of ...
Continue Reading →
Europe

Ora, Inc. Unifies its Clinical Environment with Veeva to Accelerate Trial Execution

Fast-growing CRO adopts Veeva Vault Clinical Suite to drive greater efficiency and visibility across global studies  Veeva Systems (NYSE: VEEV), today announced that ...
Continue Reading →
Europe

Therapeutic application of mAbs will increase in near future, says GlobalData

Ever since the first commercial monoclonal antibody (mAb) was approved in 1986 for human therapeutic purposes, mAbs have been increasingly used in several areas of he...
Continue Reading →
Asia Pacific

Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X–Linked Hypophosphatemia in Children

Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx...
Continue Reading →
Europe

LifeArc announces £5M support for rare disease research

LifeArc®, the medical research charity, today announced its Philanthropic Fund will award £5M in grants to support medical research projects focused on rare diseases....
Continue Reading →
Quotient